Tackling AKI: prevention, timing of dialysis and follow-up
Author:
Publisher
Springer Science and Business Media LLC
Subject
Nephrology
Link
http://www.nature.com/articles/s41581-020-00390-3.pdf
Reference10 articles.
1. Mansour, S. G. et al. The association of angiogenesis markers with acute kidney injury and mortality after cardiac surgery. Am. J. Kidney Dis. 74, 36–46 (2019).
2. Ostermann, M. et al. Recommendations on acute kidney injury biomarkers from the acute disease quality initiative consensus conference: a consensus statement. JAMA Netw Open 3, e2019209 (2020).
3. Hapca, S. et al. The relationship between AKI and CKD in patients with type 2 diabetes: an observational cohort study. J. Am. Soc. Nephrol. https://doi.org/10.1681/ASN.2020030323 (2020).
4. Hirsch, J. S. et al. Acute kidney injury in patients hospitalized with COVID-19. Kidney Int. 98, 209–218 (2020).
5. The Division of Nephrology, Columbia University Vagelos College of Physicians. Disaster Response to the COVID-19 pandemic for patients with kidney disease in New York City. J. Am. Soc. Nephrol. 31, 1371–1379 (2020).
Cited by 64 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Targeting lipid droplets and lipid droplet-associated proteins: a new perspective on natural compounds against metabolic diseases;Chinese Medicine;2024-09-04
2. Liquiritigenin, an Active Ingredient of Liquorice, Alleviates Acute Kidney Injury by VKORC1-Mediated Ferroptosis Inhibition;The American Journal of Chinese Medicine;2024-08-28
3. High-volume hemofiltration does not protect human kidney endothelial and tubular epithelial cells from septic plasma-induced injury;Scientific Reports;2024-08-07
4. Alliin mitigates the acute kidney injury by suppressing ferroptosis via regulating the Nrf2/GPX4 axis;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-08-07
5. Initial renal replacement therapy (RRT) modality associates with 90-day postdischarge RRT dependence in critically ill AKI survivors;Journal of Critical Care;2024-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3